Robust genomic approaches are now available to realize improvements in efficiencies and translational relevance of cancer risk assessments for drugs and chemicals. The authors propose a path for implementation of innovative cancer risk assessment including incorporating genomic signatures to assess mechanistic relevance ...
A Cross-Sector Call to Improve Carcinogenicity Risk Assessment Through Use of Genomic Methodologies
Regulatory Toxicology and Pharmacology, 2019